Hepatitis Clinical Trials in Boston, Massachusetts

11 recruitingBoston, Massachusetts

Showing 111 of 11 trials

Recruiting
Phase 3

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Metabolic dysfunction-associated steatohepatitis (MASH)Liver Fibrosis
Boehringer Ingelheim1,800 enrolled526 locationsNCT06632444
Recruiting
Phase 3

Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

Hepatitis
Bausch Health Americas, Inc.350 enrolled48 locationsNCT07428538
Recruiting
Phase 2

A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)

Chronic Hepatitis B Infection
Aligos Therapeutics200 enrolled58 locationsNCT06963710
Recruiting

Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease

ObesityNon-Alcoholic Fatty Liver DiseaseNon Alcoholic Steatohepatitis
Brigham and Women's Hospital150 enrolled2 locationsNCT05728697
Recruiting
Phase 4

National Liver Cancer Screening Trial

Liver CancerCarcinoma, HepatocellularLiver Cirrhosis+1 more
University of Texas Southwestern Medical Center5,500 enrolled18 locationsNCT06084234
Recruiting
Not Applicable

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Insulin Sensitivity/ResistanceObesityInsulin Resistance+16 more
Pichamol Jirapinyo, MD, MPH132 enrolled2 locationsNCT06138821
Recruiting
Phase 1

Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B

Hepatitis B, Chronic
Precision BioSciences, Inc.45 enrolled4 locationsNCT06680232
Recruiting

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Lung CancerCancer RiskCancer Predisposition Syndrome+28 more
Dana-Farber Cancer Institute5,000 enrolled1 locationNCT05463796
Recruiting
Phase 3

Estrogen Administration for the Treatment of NASH in Postmenopausal Women

NASH - Nonalcoholic Steatohepatitis
Massachusetts General Hospital60 enrolled1 locationNCT04833140
Recruiting
Phase 2

FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study

Alcohol Associated Hepatitis
Intercept Pharmaceuticals80 enrolled31 locationsNCT05639543
Recruiting
Phase 2

Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)

Hepatitis B
GlaxoSmithKline450 enrolled51 locationsNCT04954859